Factor VIII and von Willebrand factor activity levels during long-term prophylaxis with wilate—Analyses from the WIL-31 study
During 12 months of wilate prophylaxis, there was no accumulation of FVIII or VWF regardless of age and VWD type, and no thrombotic events were reported. These findings from WIL-31 confirm and extend wilate's existing safety data.
Authors
- Ana Boban (ORCID: https://orcid.org/0000-0003-3532-2336)
- Robert F. Sidonio (ORCID: https://orcid.org/0000-0002-9509-9415)
- Claudia Djambas Khayat
Institutions
- University Hospital Centre Zagreb (HR)
- Emory University (US)
- University of Zagreb (HR)
- Saint Joseph University (LB)
- Hôtel-Dieu de France (LB)
Publication Details
- Journal
- Research and Practice in Thrombosis and Haemostasis
- Published
- 2025-12-31
- DOI
- https://doi.org/10.1016/j.rpth.2025.103327
- Citations
- 1
- Primary Topic
- Hemophilia Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.77